Exploring the therapeutic potential of marjoram (Origanum majorana L.) in polycystic ovary syndrome: insights from serum metabolomics, network pharmacology and experimental validation
Abstract
Using metabolomics, network pharmacology and experimental validation, marjoram (Origanum majorana) showed therapeutic potential in polycystic ovary syndrome, modulating inflammatory and metabolic pathways, indicating an anti-inflammatory effect.
Referenced for these plants
How to cite
Elfiky, A.M., Ibrahim, R.S., Khattab, A.R., Kadry, M.O. and others (2025) 'Exploring the therapeutic potential of marjoram (Origanum majorana L.) in polycystic ovary syndrome: insights from serum metabolomics, network pharmacology and experimental validation', BMC Complementary Medicine and Therapies, 25(1), pp. 67. doi:10.1186/s12906-025-04774-5
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.